Literature DB >> 9492778

Nevirapine-associated Stevens-Johnson syndrome.

K J Warren, D E Boxwell, N Y Kim, B A Drolet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9492778     DOI： 10.1016/S0140-6736(98)24008-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  HCP5 genetic variant (RS3099844) contributes to Nevirapine-induced Stevens Johnsons Syndrome/Toxic Epidermal Necrolysis susceptibility in a population from Mozambique.

Authors:  Paola Borgiani; Davide Di Fusco; Fulvio Erba; Maria C Marazzi; Sandro Mancinelli; Giuseppe Novelli; Leonardo Palombi; Cinzia Ciccacci
Journal:  Eur J Clin Pharmacol       Date:  2013-12-10       Impact factor: 2.953

2.  Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxis.

Authors:  Ayman Bannaga; Omar Rahama; Gavin Barlow
Journal:  BMJ Case Rep       Date:  2013-04-25

3.  [Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz].

Authors:  M Hartmann; J Brust; D Schuster; F Mosthaf; M Procaccianti; J A Rump; H Klinker; D Petzoldt
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

Review 4.  Hypersensitivity reactions to HIV therapy.

Authors:  Mas Chaponda; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

5.  [Exanthema simulating measles without measles virus? Allergic reaction to a non-nucleoside reverse transcriptase inhibitor in an HIV infected boy treated with HAART].

Authors:  G-M Lackmann; B Schmidt; T Niehues
Journal:  Hautarzt       Date:  2003-06-25       Impact factor: 0.751

6.  Incidence and risk factors for nevirapine-associated rash.

Authors:  Monique M R de Maat; Rob ter Heine; Jan W Mulder; Pieter L Meenhorst; Albert T A Mairuhu; Eric C M van Gorp; Alwin D R Huitema; Jos H Beijnen
Journal:  Eur J Clin Pharmacol       Date:  2003-08-12       Impact factor: 2.953

7.  Oral lesions associated with nevirapine-related Stevens Johnson syndrome: A report of four cases.

Authors:  S Balasundaram; K Ranganathan; K Umadevi; R Gunaseelan; N Kumaraswamy; Sunithi Solomon; Bella Devaleenol; Pradeep Ambrose
Journal:  J Oral Maxillofac Pathol       Date:  2011-01

8.  HIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.

Authors:  Manuela G Neuman; Michelle Schneider; Radu M Nanau; Charles Parry
Journal:  Int J Hepatol       Date:  2012-03-11

9.  A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibility.

Authors:  Cinzia Ciccacci; Sara Rufini; Sandro Mancinelli; Ersilia Buonomo; Emiliano Giardina; Paola Scarcella; Maria C Marazzi; Giuseppe Novelli; Leonardo Palombi; Paola Borgiani
Journal:  Int J Mol Sci       Date:  2015-03-12       Impact factor: 5.923

10.  Antiretroviral Therapy-associated Serious and Life-threatening Toxicities.

Authors:  Alice K. Pau
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.663
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.